Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, potentiate the anti-angiogenic effects of bevacizumab by suppressing angiopoietin2, BiP, and Hsp90α in human colorectal cancer

被引：0
|
作者：
S J Lee
I Lee
J Lee
C Park
W K Kang
机构：
[1] Samsung Medical Center,Division of Hematology
[2] Sungkyunkwan University School of Medicine,Oncology, Department of Medicine
[3] Biomedical Research Institute,undefined
[4] Samsung Medical Center,undefined
来源：
British Journal of Cancer | 2014年 / 111卷
关键词：
colorectal cancer; statins; angiogenesis; bevacizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：497 / 505
页数：8
相关论文
共 3 条
  • [1] Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, potentiate the anti-angiogenic effects of bevacizumab by suppressing angiopoietin2, BiP, and Hsp90α in human colorectal cancer
    Lee, S. J.
    Lee, I.
    Lee, J.
    Park, C.
    Kang, W. K.
    BRITISH JOURNAL OF CANCER, 2014, 111 (03) : 497 - 505
  • [2] Insights in the molecular mechanisms of the anti-angiogenic effect of an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase
    Vincent, L
    Albanese, P
    Bompais, H
    Uzan, G
    Vannier, JP
    Steg, PG
    Soria, J
    Soria, C
    THROMBOSIS AND HAEMOSTASIS, 2003, 89 (03) : 530 - 537
  • [3] Anti-inflammatory effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) in peritoneal dialysis patients
    Kumar, Sanjeev
    Raftery, Martin
    Yaqoob, Magdi
    Fan, Stanley L. -S.
    PERITONEAL DIALYSIS INTERNATIONAL, 2007, 27 (03): : 283 - 287
1